newsfilter
← Latest News
Business Wire·

Innoviva to Acquire La Jolla Pharmaceutical Company

Acquisition to strengthen Innoviva's infectious disease and hospital portfolio with addition of GIAPREZA® and XERAVA® Innoviva, Inc. (NASDAQ:INVA), a diversified holding company with a portfolio of royalties and a growing portfolio of innovativ